関連する実験動画
Updated: Jul 25, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.6K
アセチル化ターゲティングキメラは,腫瘍抑制剤p53のアセチル化を可能にします
Md Kabir1, Ning Sun1, Xiaoping Hu1
1Mount Sinai Center for Therapeutics Discovery, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Journal of the American Chemical Society
|June 27, 2023
まとめ
腫瘍抑制タンパク質p53を アセチル化によって活性化させる 新しいACETAC戦略を開発しました このアプローチは,p53Y220C変異を持つ癌細胞を成功裏に標的とし,新しい治療法を提供しました.
科学分野:
- 生物化学
- 分子生物学
- 腫瘍学
背景:
- PROTACのような 化学的に誘発された近接技術は 癌の治療に進歩しました
- 薬理学的な活性化のために腫瘍抑制タンパク質をターゲットにすることは,がん治療における課題です.
研究 の 目的:
- 標的型タンパク質アセチル化のための新しいAceTAC戦略を導入する.
- p53腫瘍抑制タンパク質の特定のACETACを開発し,特徴づけること.
主な方法:
- 最初のp53Y220C AceTACの発見と特徴付け,MS78.
- MS78は,p53Y220Cアセチル化のためのヒストンアセチルトランスファーゼp300/CBPを募集するために使用されました.
- 癌細胞の増殖,クローン遺伝性,遺伝子発現 (RNA-seq) に関するMS78の影響を評価した.
主要な成果:
- MS78は,K382でp53Y220Cを,投与量,時間,およびp300に依存した方法で効果的にアセチル化した.
- MS78はp53Y220C変異がん細胞における増殖とクローン遺伝性を抑制し,野生型p53細胞に対する毒性は最小限であった.
- MS78によるアセチル化は,TRAILアポプトシス遺伝子のアップレギュレーションとDNAダメージ応答経路のダウンレギュレーションをもたらした.
結論:
- AceTAC戦略は,アセチル化による腫瘍抑制剤を含むタンパク質を標的とする一般的なプラットフォームを提供します.
- MS78は,p53Y220C変異を有するがんの治療薬としての可能性を示しています.
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K

